Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels |
|---|---|---|---|
| 1 | |||
| Abdominal pain | x | ||
| Agranulocytosis | x | ||
| Angioedema | x | ||
| Rash | x | ||
| Hepatitis | x | ||
| Hypersensitivity | x | ||
| Neutropenia | x | ||
| Convulsion | x | ||
| Urticaria | x | ||
| Prolonged menses | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |